Global heart study seeks to settle Blood-Thinner debate
NCT ID NCT03252249
Summary
This large international study aimed to find the safest length of time for patients to take two blood-thinning drugs after a heart attack. It compared shorter and longer treatment durations to see which better balanced the risk of future heart problems against the risk of serious bleeding. The trial involved over 5,000 patients and used real-world health records to track outcomes efficiently.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Edinburgh Royal Infirmary
Edinburgh, United Kingdom
Conditions
Explore the condition pages connected to this study.